Accardi Mario Alberto - Insider Non-Derivative Transactions at Centessa Pharmaceuticals plc (CNTA) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 9, 2025, Accardi Mario Alberto's relationship to Centessa Pharmaceuticals plc (CNTA) is Officer (President, Orexin Program), and currently has 181,369 shares of Ordinary Shares.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other CNTA insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Accardi Mario Alberto - Insider Non-Derivative Transactions of CNTA Ordinary Shares

Accardi Mario Alberto - Insider Non-Derivative Transactions at CNTA

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 10, 2025	Sell -- (Ordinary Shares)	2568	29.21	178801
Dec 10, 2025	Sell -- (Ordinary Shares)	7432	28.7	181369
Dec 9, 2025	Sell -- (Ordinary Shares)	10000	30	188801
Dec 9, 2025	M -- (Ordinary Shares)	5000	9.53	198801
Nov 2, 2025	F -- (Ordinary Shares)	593	24.9	193801
Oct 28, 2025	Sell -- (Ordinary Shares)	8000	25	194394
Oct 28, 2025	M -- (Ordinary Shares)	5000	8.01	202394
Sep 17, 2025	Sell -- (Ordinary Shares)	742	22.02	197394
Sep 17, 2025	Sell -- (Ordinary Shares)	7430	21.33	198136
Sep 10, 2025	Sell -- (Ordinary Shares)	7000	20	205566
Sep 10, 2025	M -- (Ordinary Shares)	5000	8.01	212566
Aug 2, 2025	F -- (Ordinary Shares)	597	17.17	207566
Jul 30, 2025	Sell -- (Ordinary Shares)	8322	15.23	208163
Jun 25, 2025	Sell -- (Ordinary Shares)	15000	14	216485
Jun 25, 2025	M -- (Ordinary Shares)	15000	3.85	231485